BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 88 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $1,142,000 | +977.4% | 76,498 | +551.0% | 0.06% | +966.7% |
Q1 2015 | $106,000 | -45.9% | 11,751 | -26.9% | 0.01% | -62.5% |
Q4 2014 | $196,000 | -51.7% | 16,084 | -49.6% | 0.02% | -51.5% |
Q2 2014 | $406,000 | -38.4% | 31,882 | -48.8% | 0.03% | -71.6% |
Q1 2014 | $659,000 | +53.3% | 62,306 | +10.2% | 0.12% | +107.1% |
Q4 2013 | $430,000 | +101.9% | 56,551 | +93.4% | 0.06% | +40.0% |
Q3 2013 | $213,000 | – | 29,243 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |